4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000007
Chief Legal Officer sold 1,760 shares at $7.99 ($14,063)
- Chief Legal Officer acquired 3,924 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-30 | Exercise or conversion : show line 1 in the form | +1,924 | 17,187 | D | ||
| 2024-01-30 | Exercise or conversion : show line 2 in the form | +2,000 | 19,187 | D | ||
| 2024-01-30 | Sale : show line 3 in the form | −1,760 | $7.99 | $14,063 | 17,427 | D |
| Open-market sales · 1,760 sh · avg $7.99 · $14,063 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-30 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −1,924 | 15,393 | D |
| 2024-01-30 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −2,000 | 18,000 | D |
Loading xslF345X05/wk-form4_1706658755.xml…